China Pharma Holdings (CPHI) Debt Ratio (2016 - 2025)
Historic Debt Ratio for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.12.
- China Pharma Holdings' Debt Ratio fell 3250.21% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 3250.21%. This contributed to the annual value of 0.17 for FY2024, which is 1020.77% up from last year.
- As of Q3 2025, China Pharma Holdings' Debt Ratio stood at 0.12, which was down 3250.21% from 0.2 recorded in Q2 2025.
- China Pharma Holdings' 5-year Debt Ratio high stood at 0.24 for Q3 2021, and its period low was 0.12 during Q3 2025.
- Its 5-year average for Debt Ratio is 0.17, with a median of 0.17 in 2023.
- As far as peak fluctuations go, China Pharma Holdings' Debt Ratio soared by 6152.39% in 2021, and later crashed by 3250.21% in 2025.
- Quarter analysis of 5 years shows China Pharma Holdings' Debt Ratio stood at 0.19 in 2021, then decreased by 28.19% to 0.14 in 2022, then grew by 12.62% to 0.15 in 2023, then grew by 10.21% to 0.17 in 2024, then decreased by 27.35% to 0.12 in 2025.
- Its Debt Ratio stands at 0.12 for Q3 2025, versus 0.2 for Q2 2025 and 0.18 for Q1 2025.